Braveheart is pleased to provide an update concerning the development of a COVID-19 test that Paraytec Limited is conducting with the University of Sheffield.
Overview facts about hVIVO COVID Clear & FAQ
Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical
TPI provides its latest research note on Integumen plc (SKIN.L)
Positioning itself to secure revenues in a post-Pandemic environment desperate to mitigate potential risk of re-transmission of COVID-19 or similar future viruses, Integumen has today announced that its subsidiary, Labskin,
Open Orphan PLC (LON:ORPH) Appointment of Group Chief Financial Officer
Cathal Friel, Executive Chairman of Open Orphan said: “I am delighted that we have appointed Leo as CFO. He has worked with Open Orphan for the past year and is